CME Group Inc. (NASDAQ:CME) Shares Acquired by Oak Harvest Investment Services

Oak Harvest Investment Services increased its stake in CME Group Inc. (NASDAQ:CME) by 5.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 53,775 shares of the financial services provider’s stock after acquiring an additional 2,639 shares during the quarter. CME Group makes up about 1.7% of Oak Harvest Investment Services’ portfolio, making the stock its 14th biggest holding. Oak Harvest Investment Services’ holdings in CME Group were worth $11,865,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC grew its holdings in shares of CME Group by 21.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after purchasing an additional 8,443 shares during the period. Duality Advisers LP purchased a new stake in CME Group during the 1st quarter worth about $1,455,000. SG Americas Securities LLC boosted its stake in shares of CME Group by 312.2% in the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after buying an additional 42,996 shares during the period. Cetera Investment Advisers grew its position in shares of CME Group by 429.1% during the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after buying an additional 38,540 shares in the last quarter. Finally, Brookstone Capital Management lifted its stake in CME Group by 12.2% in the second quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock worth $6,156,000 after acquiring an additional 3,325 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Up 0.1 %

Shares of NASDAQ CME opened at $227.26 on Thursday. The firm’s 50 day moving average price is $220.05 and its 200 day moving average price is $209.23. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $81.83 billion, a P/E ratio of 25.85, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.25 EPS. As a group, sell-side analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.02%. CME Group’s dividend payout ratio (DPR) is 52.33%.

Wall Street Analyst Weigh In

CME has been the subject of several recent analyst reports. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Citigroup upped their price objective on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research note on Thursday, October 24th. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Finally, Morgan Stanley raised their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $222.73.

Insider Activity

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares of the company’s stock, valued at $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of the firm’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares of the company’s stock, valued at $1,652,298. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,221 shares of company stock valued at $3,351,895 in the last three months. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.